Search

Your search keyword '"Ammirati E."' showing total 549 results

Search Constraints

Start Over You searched for: Author "Ammirati E." Remove constraint Author: "Ammirati E."
549 results on '"Ammirati E."'

Search Results

2. Coexistence of cardiac sarcoidosis and genetic cardiomyopathies: a conundrum

3. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

4. Global Burden of Cardiovascular Diseases and Risks, 1990-2022

5. Outcomes and clinical impact of early endomyocardial biopsy in patients with fulminant myocarditis

7. Acute Myocarditis Associated With Desmosomal Gene Variants

8. Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis

9. Immune checkpoint inhibitor-associated myocarditis: from pathophysiology to rechallenge of therapy - a narrative review

10. Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

11. P275 COMBINED NEURO–HUMORAL MODULATION AND OUTCOME IN PATIENTS WITH CHRONIC HEART FAILURE AND MILDLY REDUCED OR PRESERVED EJECTION FRACTION

12. P408 PREVALENCE CHARACTERISTICS AND OUTCOMES OF COVID 19 ASSOCIATED ACUTE MYOCARDITIS

13. P227 THE UNEXPECTED CONSEQUENCES OF A 30 METERS FALL

15. C84 OUTCOME AND MORPHO–FUNCTIONAL CHANGES ON CARDIAC MAGNETIC RESONANCE IN PATIENT WITH ACUTE MYOCARDITIS FOLLOWING MRNA COVID 19 VACCINATION

17. Acute myocarditis associated with desmosomal gene variants

20. A heart of iron: juvenile haemochromatosis presents with cardiac failure

22. C65 POST–DISCHARGE ARRHYTHMIC RISK STRATIFICATION OF PATIENTS WITH ACUTE MYOCARDITIS AND LIFE–THREATENING VENTRICULAR TACHYARRHYTHMIAS

23. C75 PHEOCHROMOCYTOMA–INDUCED CARDIOGENIC SHOCK: A MULTICENTER ANALYSIS OF CLINICAL PROFILES, MANAGEMENT AND OUTCOMES

25. Takotsubo syndrome as a complication in a critically ill COVID-19 patient

26. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study

28. Immunomodulatory therapies in fulminant myocarditis associated with viral infection.

29. A novel tool to predict functional outcomes after robot-assisted radical prostatectomy and the value of additional surgery for incontinence

30. Is cystoscopic sphincter evaluation a reliable witness before continence surgery? A prospective, blinded, real life, single centre study

31. Urethral bulking in the treatment of stress and mixed female urinary incontinence: results of a multicenter study on a large cohort of patients

33. Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors

34. Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction

35. Getting to the heart of the matter in a multisystem disorder: Erdheim–Chester disease

36. Association of white matter hyperintensities and cardiovascular disease

37. A Novel Artificial Urinary Sphincter (VICTO) for the Management of Postprostatectomy Urinary Incontinence: Description of the Surgical Technique and Preliminary Results from a Multicenter Series.

38. Prevalence and Outcome of Patients with Acute Myocarditis and Positive Viral Search on Nasopharyngeal Swab

39. Temporal Relation Between Second Dose BNT162b2 mRNA Covid-19 Vaccine and Cardiac involvement in a Patient with Previous SARS-COV-2 Infection

40. WITHDRAWN: Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection

42. Chronic heart failure in octogenarians. Temporal trends in clinical characteristics, treatment and outcomes over two decades in a nationwide cardiology registry

43. Chronic heart failure in younger patients: temporal trends in clinical characteristics, treatment and outcomes over two decades in a nationwide cardiology registry

48. Pregression of brain white matter hyperintensities in asymptomatic patients with carotid atherosclerosis plaques and no indication for revascularization

49. ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA)

50. Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure

Catalog

Books, media, physical & digital resources